Today's noteworthy initiations include: BankUnited (BKU) initiated with a Buy at UBS... Benefitfocus (BNFT) initiated with an Outperform at Wells Fargo... Boston Scientific (BSX) initiated with an Outperform at Raymond James... Carnival (CCL) initiated with a Neutral at Wedbush... Castlight Health (CSLT) initiated with a Market Perform at Wells Fargo... Cooper Companies (COO) initiated with an Overweight at Piper Jaffray... DISH (DISH) initiated with an Underperform at BMO Capital... FleetCor (FLT) initiated with a Perform at Oppenheimer... Headwaters (HW) initiated with a Buy at SunTrust... Heron Therapeutics (HRTX) resumed with a Buy at Jefferies... Horsehead Holding (ZINC) initiated with a Buy at BB&T... Information Services (III) initiated with a Buy at B. Riley... Maximus (MMS) initiated with an Outperform at Wells Fargo... Neovasc (NVCN) initiated with an Outperform at Leerink... Norwegian Cruise Line (NCLH) initiated with an Outperform at Wedbush... Perceptron (PRCP) initiated with a Buy at Canaccord... Regeneron (REGN) initiated with a Buy at Chardan... Rexahn (RNN) initiated with a Buy at MLV & Co.... Royal Caribbean (RCL) initiated with a Neutral at Wedbush... Sage Therapeutics (SAGE) initiated with an Outperform at William Blair... Sprouts Farmers Markets (SFM) initiated with a Neutral at Sterne Agee... SunEdison Semiconductor (SEMI) initiated with a Buy at Summit Research... The Medicines Co. (MDCO) initiated with a Neutral at Mizuho... Trimble (TRMB) initiated with a Neutral at Goldman... WEX Inc. (WEX) initiated with an Outperform at Oppenheimer... WageWorks (WAGE) initiated with an Outperform at Wells Fargo... eHealth (EHTH) initiated with a Market Perform at Wells Fargo.

Consensus for FY24 EPS is $16.25. Raises FY24 revenue view to $2.73B-$2.77B from $2.70B-$2.74B, consensus $2.73B.

Sees Q2 fuel consumption 416,000 metric tons.

Reports Q1 revenue $3.7B, consensus $3.69B. Load factors in the first quarter were 107%. "Wow, what a great start to the year! Demand for our leading brands and the incredible experiences they deliver continues to be very robust, resulting in outperformance in the first quarter, a further increase of full year earnings guidance, and 60% expected earnings growth year over year," said Jason Liberty, president and CEO, Royal Caribbean Group. "Building on this momentum, we expect to achieve all our Trifecta financial goals in 2024, which allows us to focus on a new era of growth to drive long-term shareholder returns and take a greater share of the rapidly growing $1.9 trillion global vacation market."

Reports Q1 revenue $652.7M, consensus $654.7M. "WEX delivered impressive financial results in the first quarter, including record first quarter revenue, marking a strong start to 2024 and reinforcing our ability to drive robust performance in any macroeconomic environment," said CEO Melissa Smith. "Moreover, we continued to execute against our strategic initiatives. During the quarter, we made great progress integrating our recent acquisitions, launched the pilot for an enhanced acceptance offering for our North American Mobility customers, and continued to drive innovation to expand our customer value proposition. We are also laser-focused on leveraging technology and AI to improve efficiency and further enhance our offerings. Looking ahead, I remain confident in our ability to drive growth across the business in the near- and long-term."

Baird analyst David Rescott raised the firm's price target on Boston Scientific to $84 from $79 and keeps an Outperform rating on the shares. The firm noted its 1Q24 revenue/adjusted EPS beat was the biggest over the past several years and one of the most compelling in diversified LGCP MedTech.

WEX (WEX) announced that it has reached a new long-term agreement with Booking.com (BKNG), effective April 2024. This agreement distinguishes WEX as Booking.com's preferred virtual card provider as it continues providing WEX payment solutions in support of Booking.com's payments vision to make buying and selling travel-related products and services easier for everyone. "With more than 800,000 active customer relationships worldwide, WEX is proud to work with eight of the top ten online travel agencies globally, including Booking.com," said Carlos Carriedo, WEX's Chief Operating Officer, International. "Building on years of working together, we remain committed to delivering WEX's deep expertise in both payments and travel, as well as the reliability of our technology platform, to help Booking.com power its B2B travel payment activities 24/7 and 365 days/year at scale, globally." Booking.com first became a WEX customer in 2013. Over a decade later, WEX now processes payments for Booking.com across the world.

Notable companies reporting before tomorrow's open, with earnings consensus, include Merck (MRK), consensus $1.87... Caterpillar (CAT), consensus $5.14... Comcast (CMSCA), consensus 99c... Honeywell (HON), consensus $2.17... Bristol-Myers (BMY), consensus ($4.44)... Altria (MO), consensus $1.15... Keurig Dr. Pepper (KDP), consensus 35c... GE Vernova (GEV), consensus (37c)... Royal Caribbean (RCL), consensus $1.33... Tractor Supply (TSCO), consensus $1.72... Mobileye (MBLY), consensus (6c)... Textron (TXT), consensus $1.23... LabCorp (LH), consensus $3.48... Southwest Airlines (LUV), consensus (34c)... American Airlines (AAL), consensus (29c)... Harley-Davidson (HOG), consensus $1.51.

Stifel raised the firm's price target on Boston Scientific to $83 from $70 and keeps a Buy rating on the shares. The firm said the company delivered "solid" Q1 outperformance, underpinned by "important" new product launches. Looking ahead to 2024 and beyond, Stifel believes Boston Scientific could continue outperforming their Loan Repayment Program and the firm's projections.

Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here